ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted accelerated approval to ponatinib with chemotherapy for the treatment of adults with newly ...
THOUSAND OAKS, Calif., June 14, 2024 /PRNewswire/ -- Amgen (AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved BLINCYTO ® (blinatumomab) for the treatment of adult and ...
Iclusig, a kinase inhibitor, received a positive opinion for use alongside low-intensity chemotherapy in adults with newly identified disease.
PHILADELPHIA (CBS) — A child's cancer diagnosis affects the entire family and those effects can be immense and in various forms. For the Taunk family, it means stress from the cancer and subsequent ...
Interim results of the randomized, phase 3 PhALLCON trial indicate ponatinib’s benefit over imatinib in frontline treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), ...
Older patients (≥ 55 to60 years) with B-cell acute lymphoblastic leukemia (B-ALL) have high-risk cytogenetic and molecular abnormalities, as well as Philadelphia chromosome (Ph)-positive and Ph-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results